Monthly Research Recaps
Each month we collect the latest psychedelic research papers and sort them into a clear recap. The posts cover clinical trials, patient studies, reviews, surveys, and mechanistic work without treating every paper as equally important. Use this archive to follow how the evidence changes from month to month.
Psychedelic Research Recap: April 2026
April 2026 psychedelic research highlighted clinical trials in cancer, depression, suicidality, OCD and BPD, alongside mechanistic, methodological and review papers on psychedelics, ketamine, esketamine and MDMA.
Psychedelic Research Recap: March 2026
March 2026 brought a strong run of clinical trials, real-world studies, mechanistic papers, and reviews across psilocybin, ketamine, MDMA, LSD, DMT, 5-MeO-DMT and related compounds.
Psychedelic Research Recap: February 2026
A monthly recap of psychedelic research papers published in February 2026, covering clinical studies, microdosing, belief, brain imaging, reviews, and trial context.
Psychedelic Research Recap: January 2026
January 2026 brought several clinical reports, a healthy volunteer study on time perception, and broader reviews on how psychedelic therapies may fit into care systems.
Psychedelic Research Recap December 2025
In December 2025, psychedelic studies ranged from tightly controlled placebo designs to open-label clinic pilots and real-world chart reviews, with several
Psychedelic Research Recap November 2025
Psychedelic research in November examined microdosing outcomes, brain criticality and plasticity mechanisms, and clinical applications for depression, PTSD, and
Psychedelic Research Recap October 2025
Psychedelic research in October investigated brain plasticity, set and setting, and microdosing.
Psychedelic Research Recap September 2025
Psychedelic research in September focussed on MDMA, psilocybin, LSD, and ayahuasca clinical trials across diverse indications.
Psychedelic Research Recap August 2025
Psychedelic research in August 2025 (162 studies, 10 added to the database) looked at psilocybin for PTSD, economic evaluations, and much more.
Psychedelic Research Recap July 2025
Psychedelic research in July 2025 (181 studies, 18 in database) looked at the receptors psychedelics influence, naturalistic psychedelic use.
Psychedelic Research Recap June 2025
Psychedelic research in June 2025 (146 studies, 18 added to the database) looked at long-term effects of psilocybin therapy for depression, 'meaning of life'
Psychedelic Research Recap May 2025
Psychedelic research in May 2025 shows ketamine saves healthcare costs, esketamine remains safe long-term, and these therapies work differently than expected.
Psychedelic Research Recap April 2025
In April 2025, psychedelic researchers published 172 studies and we've added 17 new papers to the database. This month featured ketamine for smoking cessation
Psychedelic Research Recap March 2025
In March 2025, 138 psychedelic studies were published we've added 11 new papers to the database.
Psychedelic Research Recap February 2025
February 2025's psychedelic research explores therapeutic applications, mechanisms of action, brain effects, and emotional experiences with 11 new studies.
Psychedelic Research Recap January 2025
In January 2025, psychedelic research saw modest activity, contributing 11 new studies and 183 linked studies.
Psychedelic Research Recap December 2024
In December 2024, psychedelic research slowed, adding 14 studies, 130 links, and insights on clinical trials, re-analyses, and global progress.
Psychedelic Research Recap November 2024
In the November recap, we explore the neuroplasticity mechanisms of psychedelics, their therapeutic applications for mental health conditions.
Psychedelic Research Recap October 2024
In October we investigate discontinuation (or the lack of this) and psychedelic treatments, 2C-B effects, and neurofeedback and psychedelics.
Psychedelic Research Recap September 2024
Psychedelic research in September 2024 covered mescaline dosing, meditation, psilocybin for veterans, harmine dosing, and more
Psychedelic Research Recap July & August 2024
The psychedelic research from July and August 2024. Covering LSD follow-up, R vs S-MDMA, and false insights after psychedelics.
Psychedelic Research Recap June 2024
Psychedelic research in June 2024 investigated the coupling of psychedelics (and benzos), the role of purging, and ethical guidelines
Psychedelic Research Recap May 2024
Psychedelic research in May 2024 investigates awe in ketamine therapy, role of therapy in PAT, touch guidelines, and more
Psychedelic Research Recap April 2024
Psychedelic research in April 2024 covers mechanisms, challenges, MDMA effects, 5-MeO-DMT, and therapies for seizures, personality disorders, & headaches.
Psychedelic Research Recap March 2024
The latest psychedelic research from March 2024 with a look at meditation, SSRIs, and safety of psychedelics, and 17 more studies.
Psychedelic Research Recap February 2024
The latest psychedelic research from February 2024 with a look at sexuality, Switzerland's unique model, and 20 more studies.
Psychedelic Research Recap January 2024
January saw new psychedelic trials on ibogaine for TBI, DMT, & psilocybin for CCHs, alongside re-analyses on psychedelic brains, and more
Psychedelic Research Recap December 2023
December's psychedelic research (2023) looked at group therapy, personality, costs and microdosing LSD. 22 papers added.
Psychedelic Research Recap November 2023
November's psychedelic research (2023) saw advances in ayahuasca formulations and intriguing survey findings on naturalistic use.
Psychedelic Research Recap October 2023
The latest psychedelic research from October 2023, extended DMT, survey data on extended difficulties, and new trial results.
Psychedelic Research Recap September 2023
The psychedelic research that was published in September 2023. From new trials to guidelines. Psychedelic studies that were impactful.
Psychedelic Research Recap July & August 2023
Even as many of us took time off for summer vacations, researchers in the field of psychedelics persisted in their efforts. They delved deeper into
Psychedelic Research Recap June 2023
June was jam-packed with psychedelic research, with (again) adding nearly one paper a day to the research database of Blossom.
Psychedelic Research Recap May 2023
MDMA & LSD, masking ketamine with anaesthesia, and no blinding. This and more in the May 2023 psychedelic research recap.
Psychedelic Research Recap April 2023
April was a month marked by nearly a dozen brain imaging studies on the effects of psychedelics. Jumping out is the highly anticipated extended DMT study.
Psychedelic Research Recap March 2023
March psychedelic research investigated LSD microdosing, brain mechanisms, borderline personality disorder. All captured in our recap.
Psychedelic Research Recap February 2023
February presented another productive month for psychedelic research. This recap covers intracellular neuroplasticity, EU regulation, and more
Psychedelic Research Recap January 2023
This January, outcomes of psychedelic use were closely examined. Studies looked at how experiences are integrated, how challenging experiences lead to growth.
Psychedelic Research Recap December 2022
In December we saw medium dose of psilocybin for depression, paradoxical wakefulness on 5-MeO-DMT, many ketamine studies
Psychedelic Research Recap November 2022
In November, psilocybin can treat TRD, antidepressants weaken the effects of psilocybin and ketanserin can stop an LSD trip.
Psychedelic Research Recap October 2022
In October, natural language processing predicted clinical outcomes, esketamine is assessed in the real world & tolerance in microdosing.
Psychedelic Research Recap September 2022
Research from September shows the effectivness of ketamine in the real world, how LSD can treat anxiety & how psychedelics work in the brain.
Psychedelic Research Recap July & August 2022
Psychedelic research in July and August 2022 moved forward with the largest psychedelic trail on addiction taking place.
Psychedelic Research Recap June 2022
Psychedelic Research in June 2022 continued at pace with re-analysis of earlier data, surveys, and some clinical trials.
Psychedelic Research Recap May 2022
May was another busy month for psychedelic research as we gained further insight into how psychedelics work in the brain and more.
Psychedelic Research Recap April 2022
Over April, we continued to learn more about psychedelic medicine. Researchers argued that psilocybin increases global integration.
Psychedelic Research Recap March 2022
March was another busy month in psychedelic medicine with nearly 100 publications of trials, surveys, reviews, etc.
Psychedelic Research Recap February 2022
February was another productive month for psychedelic research. LSD vs psilocybin, and a 12-month follow-up.
Psychedelic Research Recap January 2022
January brought with it the largest published clinical trial with psilocybin to date | Ketamine effective for alcoholism not PTSD for veterans
Psychedelics Research Recap December 2021
December psychedelic research 2021 | Microdosing studies | Synthesizing MDMA & structure of psilocybin examined | NO2 review
Psychedelics Research Recap November 2021
November psychedelic research 2021 | Psychedelics alter beliefs, reduce opioid use, & the effects of microdosing | Phase I trial clear 5-MeO-DMT
Psychedelics Research Recap October 2021
October brought 26 research articles on psychedelics as medicine. Several studies explored the effects of low doses of LSD ...
Psychedelics Research Recap September 2021
September featured 30 new and exciting papers on psychedelics | Safety of psychedelics | Well-being after the ceremonial or therapeutic use
Psychedelics Research Recap July & August 2021
Psychedelic research continued at pace during the summer of 2021 | Risks of psychedelics | Benefits when treating addictions
Psychedelics Research Recap June 2021
Psychedelic research in June 2021 | From those who use mental health services to the general public | fMRI studies new findings
Psychedelics Research Recap May 2021
Psychedelic research in May 2021 | MAPS MDMA study data | psychedelics and genes | Many psychedelic centre studies
Psychedelics Research Recap April 2021
Psychedelic research in April 2021 | Psychedelics against SSRIs | Mice take a break from tripping | New psychedelics discovered
Psychedelics Research Recap March 2021
March 2021 psychedelic research started with the largest microdosing study with psilocybin, LSD, and other psychedelics.
Psychedelics Research Recap February 2021
February 2021 was another great month for psychedelic research. The BIMA study used MDMA-assisted psychotherapy for alcoholism (AUD)
Psychedelics Research Recap January 2021
Psychedelic research in January 2021 | A meta-analytic review found psychedelics to improve the mood of patients with depression
Psychedelics Research Recap December 2020
This December 2020, psychedelic research looked into many different aspects of the psychedelic experience | Nature-relatedness
Psychedelics Research Recap November 2020
This November 2020 proved to be another fruitful month for psychedelic research | Psychedelics for more mental illnesses
Psychedelics Research Recap October 2020
October was possibly the most active month this year for psychedelic research | These are building blocks that further the psychedelic field
Psychedelics Research Recap September 2020
September 2020 psychedelic research looked at the increased neuronal growth (flexibility in the brain) that psychedelics elicit
Psychedelics Research Recap August 2020
Psychedelic research slowed down a bit during this August 2021 | The effect of 20 µg LSD on increasing pain tolerance was widely reported
Psychedelics Research Recap July 2020
July 2020 study compares ketamine unfavourably to ECT | Psychedelics for anxiety disorder & psilocybin specifically for OCD
Psychedelics Research Recap June 2020
Psychedelic trials are getting larger in June 2020 | Long-term follow-up of Phase II MDMA for PTSD still showing benefits
Psychedelics Research Recap May 2020
May 2020 psychedelic research on alcoholism & psychedelics in animals | Research into our brainwaves (with DMT and LSD)
Psychedelics Research Recap April 2020
April has been a slow month for psychedelic research | Microdosing psychedelics remains interesting, yet not studied in a very controlled way
Psychedelics Research Recap March 2020
New evidence for psychedelics in the fight against depression | Classical psychedelics seem to be longer-lasting than ketamine
Psychedelics Research Recap February 2020
Psychedelics may not be ready to be accepted by the FDA | The use of psilocybin has positive effects one month later
Psychedelics Research Recap January 2020
This very first psychedelic research analysis by Blossom features two outstanding papers on psychedelics that were published in January 2020